We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$579M
AUM Growth
+$1.24M
Cap. Flow
-$7.68M
Cap. Flow %
-1.33%
Top 10 Hldgs %
26.66%
Holding
911
New
84
Increased
147
Reduced
361
Closed
94

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.76M
2
VST icon
Vistra
VST
+$5.89M
3
DXC icon
DXC Technology
DXC
+$5.64M
4
IRM icon
Iron Mountain
IRM
+$4.73M
5
CTVA icon
Corteva
CTVA
+$4.5M

Sector Composition

Rank Sector Weight
1 Technology 14.31%
2 Healthcare 13.42%
3 Financials 10.65%
4 Industrials 9.97%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$24.5M 4.23%
495,032
+1,424
+0.3% +$69.4K
GVI icon
2
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
$19.5M 3.38%
173,977
+14,182
+9% +$1.57M
MSFT icon
3
Microsoft
MSFT
$3.62T
$16.6M 2.86%
123,556
-20,514
-14% -$2.6M
JNJ icon
4
Johnson & Johnson
JNJ
$621B
$14.8M 2.55%
106,137
-7,766
-7% -$1.07M
AVGO icon
5
Broadcom
AVGO
$1.99T
$14.3M 2.47%
497,570
-19,770
-4% -$576K
UNH icon
6
UnitedHealth
UNH
$375B
$14.2M 2.45%
58,158
+360
+0.6% +$86.6K
CVS icon
7
CVS Health
CVS
$126B
$13.2M 2.28%
242,586
+48,039
+25% +$2.59M
CMCSA icon
8
Comcast
CMCSA
$87.8B
$12.7M 2.2%
301,310
-52,509
-15% -$2.22M
JPM icon
9
JPMorgan Chase
JPM
$955B
$12.6M 2.17%
112,357
-32,185
-22% -$3.55M
PEP icon
10
PepsiCo
PEP
$189B
$11.9M 2.06%
90,736
-651
-0.7% -$83.5K
MMM icon
11
3M
MMM
$93.9B
$11.8M 2.04%
81,428
+11,301
+16% +$1.74M
BMY icon
12
Bristol-Myers Squibb
BMY
$130B
$11.5M 1.99%
253,792
+145,228
+134% +$6.76M
RTN
13
DELISTED
Raytheon Company
RTN
$10.9M 1.89%
62,857
-1,167
-2% -$210K
MCD icon
14
McDonald's
MCD
$195B
$10.9M 1.88%
52,433
-130
-0.2% -$25.8K
BG icon
15
Bunge Global
BG
$20.5B
$10.5M 1.81%
188,378
+6,352
+3% +$339K
AMZN icon
16
Amazon
AMZN
$2.94T
$9.6M 1.66%
101,420
-2,580
-2% -$240K
MO icon
17
Altria Group
MO
$114B
$9.29M 1.61%
196,212
-33,907
-15% -$1.78M
HBI
18
DELISTED
Hanesbrands
HBI
$9.2M 1.59%
533,992
-46,807
-8% -$806K
LMT icon
19
Lockheed Martin
LMT
$133B
$8.98M 1.55%
24,704
-780
-3% -$261K
WFC icon
20
Wells Fargo
WFC
$270B
$8.81M 1.52%
186,239
+79,984
+75% +$3.74M
AMGN icon
21
Amgen
AMGN
$220B
$8.59M 1.48%
46,627
+973
+2% +$174K
RDS.A
22
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$8.56M 1.48%
131,618
-10,268
-7% -$657K
BAC icon
23
Bank of America
BAC
$442B
$8.37M 1.45%
288,628
-26,117
-8% -$753K
VTI icon
24
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$8.07M 1.39%
53,752
+806
+2% +$119K
EIX icon
25
Edison International
EIX
$26.3B
$8.05M 1.39%
119,404
+37,381
+46% +$2.32M

Similar funds

Howe & Rusling's Q2 2019 Portfolio in Review

As of Q2 2019, Howe & Rusling held 911 positions worth $579M, up 0.21% from $577M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Howe & Rusling's Q2 2019 filing shows 84 new, 147 increased, 361 reduced and 94 closed positions. Its largest new stake was Iron Mountain: 144,315 shares worth $4.52M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Howe & Rusling's largest Q2 2019 buy was Iron Mountain: 144,315 shares worth $4.52M.
  • Howe & Rusling added most to Bristol-Myers Squibb in Q2 2019, an estimated $6.76M increase.
  • Howe & Rusling's biggest Q2 2019 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $10.4M.
  • Howe & Rusling fully exited iShares MSCI USA Quality Factor ETF in Q2 2019, selling an estimated $1.19M.
  • Howe & Rusling's ten largest holdings make up 27% of its $579M portfolio in Q2 2019.
  • Howe & Rusling opened 84 new positions and closed 94 in Q2 2019.
  • Howe & Rusling's portfolio value rose 0.21% quarter-over-quarter to $579M.

Based on Howe & Rusling's 13F filing for Q2 2019, filed 12 Aug 2019.